Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Licht

Blood

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Blood|February 26, 2011
MEK and MAF in myeloma therapyRelja Popovic, Jonathan D Licht
Blood|May 20, 2008
Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cellsJose M Polo, Weimin Ci, Jonathan D Licht, et al.
Blood|April 18, 2012
Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2Pradeep Sathyanarayana, Arvind Dev, Anamika Pradeep, et al.
Blood|February 26, 2004
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRTShinichiro Takahashi, Melanie J McConnell, Hideo Harigae, et al.
Blood|April 3, 2009
Survivin is not required for the endomitotic cell cycle of megakaryocytesQiang Wen, Cindy Leung, Zan Huang, et al.
Blood|October 11, 2003
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoproteinNathalie Chevallier, Connie M Corcoran, Christine Lennon, et al.
Blood|December 31, 2011
miR-27b controls venous specification and tip cell fateDauren Biyashev, Dorina Veliceasa, Jacek Topczewski, et al.
Blood|May 31, 2018
USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanismJohanna Melo-Cardenas, Yuanming Xu, Juncheng Wei, et al.
Blood|October 27, 2009
Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYCKim L Rice, Itsaso Hormaeche, Sergei Doulatov, et al.
Blood|August 5, 2009
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationMaria E Figueroa, Lucy Skrabanek, Yushan Li, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Blood|February 26, 2011
MEK and MAF in myeloma therapyRelja Popovic, Jonathan D Licht
Blood|May 20, 2008
Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cellsJose M Polo, Weimin Ci, Jonathan D Licht, et al.
Blood|April 18, 2012
Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2Pradeep Sathyanarayana, Arvind Dev, Anamika Pradeep, et al.
Blood|February 26, 2004
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRTShinichiro Takahashi, Melanie J McConnell, Hideo Harigae, et al.
Blood|April 3, 2009
Survivin is not required for the endomitotic cell cycle of megakaryocytesQiang Wen, Cindy Leung, Zan Huang, et al.
Blood|October 11, 2003
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoproteinNathalie Chevallier, Connie M Corcoran, Christine Lennon, et al.
Blood|December 31, 2011
miR-27b controls venous specification and tip cell fateDauren Biyashev, Dorina Veliceasa, Jacek Topczewski, et al.
Blood|May 31, 2018
USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanismJohanna Melo-Cardenas, Yuanming Xu, Juncheng Wei, et al.
Blood|October 27, 2009
Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYCKim L Rice, Itsaso Hormaeche, Sergei Doulatov, et al.
Blood|August 5, 2009
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationMaria E Figueroa, Lucy Skrabanek, Yushan Li, et al.
Pageof 2